Related Experiment Video
Updated: Jul 14, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.
Melissa L Precopio1, Michael R Betts, Janie Parrino
1Immunology Laboratory, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Vaccinia virus vaccines induce highly functional CD8(+) T cells, crucial for lifelong smallpox immunity. Understanding these T cell responses provides a benchmark for evaluating other vaccine efficacies.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Vaccinia virus immunization confers lifelong smallpox protection, yet the underlying immunological mechanisms remain unclear.
- Investigating the characteristics of CD8(+) T cells is key to understanding vaccine-induced immunity.
Purpose of the Study:
- To characterize the functional and phenotypic profile of CD8(+) T cells induced by vaccinia virus immunization.
- To compare T cell responses generated by Modified Vaccinia Ankara (MVA) and Dryvax vaccines.
Main Methods:
- Utilized polychromatic flow cytometry to analyze CD8(+) T cell populations.
- Assessed vaccine efficacy through comparative trials involving MVA and Dryvax, followed by Dryvax challenge.
Main Results:
- CD8(+) T cells induced by both MVA and Dryvax demonstrated high polyfunctionality, producing multiple cytokines (IFN-γ, IL-2, TNF-α) and chemokines (MIP-1β).
- These vaccinia virus-specific CD8(+) T cells exhibited a distinct phenotype (CD45RO(-)CD27(intermediate)).
- This polyfunctional and phenotypically unique T cell response was also observed for recombinant NYVAC expressing HIV genes.
Conclusions:
- The polyfunctional and unique CD8(+) T cell response induced by vaccinia virus likely contributes significantly to vaccine efficacy against smallpox.
- These findings establish a benchmark for evaluating the quality of CD8(+) T cell responses elicited by other vaccines.
More Related Videos
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Related Concept Videos
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Chickenpox